Taking a gamble by purchasing the rights to an underperforming narcolepsy drug may soon begin paying dividends for Axsome ...
Investing.com -- Shares of Axsome Therapeutics (NASDAQ: AXSM) fell 5.5% following the announcement of its phase 3 trial results for Solriamfetol in adults with ADHD, which achieved its primary ...
Grimes, who shares three kids with former partner Elon Musk, opens up about reading autism and ADHD diagnoses. Keep reading to know more.
A journalist at The Atlantic was unintentionally added to a group chat with top U.S. national security officials discussing ...
Popular TikTok videos on ADHD are laced with misinformation, according to new research that has found inaccurate claims in about half of top 100 most-watched TikTok videos about Attention Deficit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results